Skip to main content
Erschienen in: Wiener klinische Wochenschrift 9-10/2015

01.05.2015 | original article

Impact of medical education program on COPD patients: a cohort prospective study

verfasst von: Cristian Oancea, MD PhD, Ovidiu Fira-Mladinescu, MD PhD, Assist. Prof. Bogdan Timar, Prof. Voicu Tudorache

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2015

Einloggen, um Zugang zu erhalten

Summary

Background

The main objective of this study was to assess the effects of intensive medical education courses on chronic obstructive pulmonary disease (COPD)-related rehospitalizations and emergency department visits and the secondary aim was to monitor quality of life.

Methods

This cohort prospective study included 76 group D COPD patients (pts.). Patients from the intervention group (IG, 52 pts.) underwent a program comprising two components: a comprehensive medical education program (1h/day for 5 days) and a specific drug therapy. Control group (CG, 24 pts.) received only drug therapy. Patients underwent spirometry and completed St. George’s Respiratory Questionnaire (SGRQ) at the time of inclusion and at periodical evaluations performed every three months for a year.

Results

Patients included in a medical education program showed significant decrease of exacerbation rate compared with the CG. Patients from the IG group had fewer emergency department visits within a year compared with the CG. Patients from the IG had significantly better quality of life scores (both at 3 and 6 months) compared with the CG.

Conclusions

This study reveals that an adequate medical education program is associated with a decreased rate of COPD-related hospitalizations. The implementation of a medical education program as an integrated part of therapy could lead to a more accurate self-management of the disease.
Literatur
4.
Zurück zum Zitat Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349(9061):1269–76.CrossRefPubMed Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349(9061):1269–76.CrossRefPubMed
6.
Zurück zum Zitat Yawn BP. Early Identification of exacerbations in patients with chronic obstructive pulmonary disease. J Prim Care Community Health. 2012. doi:10.1177/2150131912443827. Yawn BP. Early Identification of exacerbations in patients with chronic obstructive pulmonary disease. J Prim Care Community Health. 2012. doi:10.1177/2150131912443827.
8.
Zurück zum Zitat Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–96.CrossRefPubMed Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–96.CrossRefPubMed
9.
Zurück zum Zitat Jenkins S, Hill K, Cecins NM. State of the art: how to set up a pulmonary rehabilitation program. Respirology. 2010;15:1157–73.CrossRefPubMed Jenkins S, Hill K, Cecins NM. State of the art: how to set up a pulmonary rehabilitation program. Respirology. 2010;15:1157–73.CrossRefPubMed
10.
Zurück zum Zitat Casaburi R, Briggs DD, Donohue JF, et al. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. Chest. 2000;118(5):1294–302.CrossRefPubMed Casaburi R, Briggs DD, Donohue JF, et al. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. Chest. 2000;118(5):1294–302.CrossRefPubMed
11.
Zurück zum Zitat Ritsema TS, Bingenheimer JB, Scholting P, et al. Differences in the delivery of health education to patients with chronic disease by provider type, 2005–2009. Prev Chronic Dis. 2014;11:130175.CrossRef Ritsema TS, Bingenheimer JB, Scholting P, et al. Differences in the delivery of health education to patients with chronic disease by provider type, 2005–2009. Prev Chronic Dis. 2014;11:130175.CrossRef
12.
Zurück zum Zitat Barnes N, Calverley PMA, Kaplan A, et al. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med. 2013;13:54.CrossRefPubMedCentralPubMed Barnes N, Calverley PMA, Kaplan A, et al. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med. 2013;13:54.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Siddique HH, Olson RH, Parenti CM, et al. Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits. Int J COPD. 2012;7:719–28. Siddique HH, Olson RH, Parenti CM, et al. Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits. Int J COPD. 2012;7:719–28.
14.
Zurück zum Zitat Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J COPD. 2012;7:495–502.CrossRef Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J COPD. 2012;7:495–502.CrossRef
15.
Zurück zum Zitat Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease specific self-management intervention. Arch Intern Med. 2003;163:585–91.CrossRefPubMed Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease specific self-management intervention. Arch Intern Med. 2003;163:585–91.CrossRefPubMed
16.
Zurück zum Zitat Gadoury MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long term hospitalization in COPD. Eur Respir J. 2005;26:853–7.CrossRefPubMed Gadoury MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long term hospitalization in COPD. Eur Respir J. 2005;26:853–7.CrossRefPubMed
17.
Zurück zum Zitat Gallefoss F. The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Educ Couns. 2004;52(3):259–66.CrossRefPubMed Gallefoss F. The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Educ Couns. 2004;52(3):259–66.CrossRefPubMed
18.
Zurück zum Zitat Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George respiratory disease questionnaire. Am Rev Respir Dis. 1992;145:1321–7.CrossRefPubMed Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George respiratory disease questionnaire. Am Rev Respir Dis. 1992;145:1321–7.CrossRefPubMed
19.
Zurück zum Zitat Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.CrossRefPubMedCentralPubMed Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:332–8.CrossRefPubMed Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:332–8.CrossRefPubMed
21.
Zurück zum Zitat Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–51.PubMedCentralPubMed Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–51.PubMedCentralPubMed
22.
Zurück zum Zitat Crooks SW, Bayley DL, Hill SL, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000;15:274–80.CrossRefPubMed Crooks SW, Bayley DL, Hill SL, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000;15:274–80.CrossRefPubMed
23.
Zurück zum Zitat Kosmas EN, Zorpidou D, Vassilareas V, et al. Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis. Chest. 1997;112:341–7.CrossRefPubMed Kosmas EN, Zorpidou D, Vassilareas V, et al. Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis. Chest. 1997;112:341–7.CrossRefPubMed
24.
Zurück zum Zitat Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–13.CrossRefPubMed Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–13.CrossRefPubMed
Metadaten
Titel
Impact of medical education program on COPD patients: a cohort prospective study
verfasst von
Cristian Oancea, MD PhD
Ovidiu Fira-Mladinescu, MD PhD
Assist. Prof. Bogdan Timar
Prof. Voicu Tudorache
Publikationsdatum
01.05.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 9-10/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0712-z

Weitere Artikel der Ausgabe 9-10/2015

Wiener klinische Wochenschrift 9-10/2015 Zur Ausgabe

MUW researcher of the month

Researcher of the month

mitteilungen der gesellschaft

ÖGIM FLIP